stockrow
Thursday 12 November 2026
Export INCY’s income statement to Excel — free account
Incyte Corporation
INCYIncyte Corporation’s revenue for fiscal 2025 (year ended December 2025) was $5.1 billion, up 21.2% from fiscal 2024.
- Revenue
- +14.0%
- EPS
- −277.9%
- Free cash flow
- −233.0%
- Total debt
- −10.5%
Quarter to September 2026, against a year earlier
121.89
0.38
−0.31%
Follow INCY
Alert me
Incyte Corporation (INCY) Current ratio
Incyte Corporation's current ratio at the end of the quarter to 30 September 2026 was 3.8×, up 0.5× from fiscal 2025 (3.3×). Over the past ten years it has ranged from 2.0× (fiscal 2024) to 5.0× (fiscal 2015); the current reading is higher than 18% of that period. That is below the Biotechnology industry median of 4.7× and above the Healthcare sector median of 3.2×.
Current ratio, annual
Embed this chart
Annual newest first
| Period | Current ratio | Change |
|---|---|---|
| FY2025 | 3.3× | 68.07% |
| FY2024 | 2.0× | (47.32%) |
| FY2023 | 3.7× | 5.88% |
| FY2022 | 3.5× | (3.10%) |
| FY2021 | 3.7× | (2.36%) |
| FY2020 | 3.7× | (22.66%) |
| FY2019 | 4.8× | 12.20% |
| FY2018 | 4.3× | 7.48% |
| FY2017 | 4.0× | 10.28% |
| FY2016 | 3.6× | (27.50%) |
Quarterly newest first
| Period | Current ratio | Change |
|---|---|---|
| Sep 2026 | 3.8× | (16.39%) |
| Jun 2026 | 4.6× | 24.76% |
| Mar 2026 | 3.7× | 11.04% |
| Dec 2025 | 3.3× | 3.76% |
| 43 more quarters | Free account |
Against its own ten years
Low 2.0×
High 5.0×
Ten-year median
3.7×
Current reading's percentile
18
Current ratio against peers
| Company | Current ratio |
|---|---|
| ROIV Roivant Sciences Ltd. compare | 15.6× |
| BNTX BioNTech SE Sponsored ADR compare | 8.6× |
| INCY Incyte Corporation | 3.8× |
| EXEL Exelixis, Inc. compare | 3.2× |
| ASND Ascendis Pharma A/S compare | 3.0× |
| INSM Insmed, Inc. compare | 2.9× |
| ALNY Alnylam Pharmaceuticals, Inc. compare | 2.5× |
| GMAB Genmab A/S Sponsored ADR compare | 2.5× |
| JAZZ Jazz Pharmaceuticals PLC compare | 1.8× |
| Biotechnology industry median | 4.7× |
| Healthcare sector median | 3.2× |
| Market median | 1.6× |
What Current ratio is
Current Ratio shows whether a company’s short-term assets are enough to cover the bills and debts it must pay within the next year.
Current Assets (Total) ÷ Current Liabilities (Total)
More on INCY
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement